Author:
Nie Kai,Zhu Lin,Zhang Yuxuan,Chen Yinan,Parrington John,Yu Hong
Abstract
Abstract
Background
The aim of this study was to develop a nomogram by combining chest computed tomography (CT) images and clinicopathological predictors to assess the survival outcomes of patients with primary pulmonary lymphoepithelial carcinoma (PLEC).
Methods
113 patients with stage I–IV primary PLEC who underwent treatment were retrospectively reviewed. The Cox regression analysis was performed to determine the independent prognostic factors associated with patient’s disease-free survival (DFS) and cancer-specific survival (CSS). Based on results from multivariate Cox regression analysis, the nomograms were constructed with pre-treatment CT features and clinicopathological information, which were then assessed with respect to calibration, discrimination and clinical usefulness.
Results
Multivariate Cox regression analysis revealed the independent prognostic factors for DFS were surgery resection and hilar and/or mediastinal lymphadenopathy, and that for CSS were age, smoking status, surgery resection, tumor site in lobe and necrosis. The concordance index (C‑index) of nomogram for DFS and CSS were 0.777 (95% CI: 0.703–0.851) and 0.904 (95% CI: 0.847–0.961), respectively. The results of the time‑dependent C‑index were internally validated using a bootstrap resampling method for DFS and CSS also showed that the nomograms had a better discriminative ability.
Conclusions
We developed nomograms based on clinicopathological and CT factors showing a good performance in predicting individual DFS and CSS probability among primary PLEC patients. This prognostic tool may be valuable for clinicians to more accurately drive treatment decisions and individualized survival assessment.
Funder
Shanghai Pujiang Program
Shanghai Health Research Foundation for Talents
National Natural Science Foundation of China
Shanghai Municipal Commission of Science and Technology
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Hu Y, Ren S, Liu Y, et al. Pulmonary lymphoepithelioma-like carcinoma: a mini-review. Onco Targets Ther. 2020;13(undefined):3921–9.
2. Liang Y, Wang L, Zhu Y, et al. Primary pulmonary lymphoepithelioma-like carcinoma: fifty-two patients with long-term follow-up. Cancer. 2012;118(19):4748–58. 10.10 02/cncr.274.52.
3. Qin Y, Gao G, Xie X Clinical features and prognosis of pulmonary lymphoepithelioma-like carcinoma: summary of eighty-five cases. Clin Lung Cancer., 2019;20(3): e329?e337
4. Bégin LR, Eskandari J, Joncas J et al. Epstein-Barr virus related lymphoepithelioma-like carcinoma of lung. J Surg Oncol, 1987, 36(4): 280–283.
5. He J, Shen J, Pan H, et al. Pulmonary lymphoepithelioma-like carcinoma: a surveillance, epidemiology, and end results database analysis. J Thorac Dis. 2015;7(12):2330–8.